Upgrade to SI Premium - Free Trial

Bernstein SocGen Group Reiterates Market Perform Rating on BioNTech (BNTX)

June 5, 2026 9:00 AM
Bernstein SocGen Group analyst Jeffrey Walch reiterated a Market Perform rating and $96.00 price target on BioNTech (NASDAQ: BNTX).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments